Virtual Event | April 30, 2026

Return of Radiopharmaceuticals: Overcoming Operational Challenges And New Opportunities

Source: Life Science Leader

Radiopharmaceuticals and radioligand therapies were involved in multibillion dollar M&A transactions over the last several years. Panelists on this Life Science Leader virtual event discussed emerging technologies and radioisotopes, what new market opportunities exist, and what manufacturing and delivery challenges remain for radiopharmaceutical developers.  

access the Virtual Event!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

Please tell us more about you so that we can customize our newsletters to your specific interests: